glp-1 injectables How Do Injections Help with Medical Weight Loss? Best Time to Take GLP-1

Carnitine metabolism and functions

2021;320(3):E527-E538

The GLP-1 RAs appear to modify atherosclerosis in the arteries, much like statin medications that treat cholesterol, and takes about a year or more to demonstrate measurable benefits on risk for cardiovascular events, whereas the SGLT2i medications seem to affect heart and kidney function more prominently and faster, with benefits evident very soon after starting the medication

We report a DKA rate at 5 years of 2.1%

However, the speed at which these changes occur with GLP-1 therapies suggests that at least part of the effect may be independent of weight loss or glucose control